CN Patent

CN115551484A — 一种法匹拉韦组合物及其制备方法

Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2022-12-30 · 3y expired

What this patent protects

一种法匹拉韦组合物、法匹拉韦片剂及其制备方法，组合物包含法匹拉韦或其盐、占组合物重量百分比为2.5％‑15％的崩解剂羧甲基淀粉钠或羧甲基纤维素钙中的一种或两种组合和粘合剂。法匹拉韦组合物药物含量高，可实现法匹拉韦的快速释放，在体外溶出试验中能够在15分钟溶出≥85％。

USPTO Abstract

一种法匹拉韦组合物、法匹拉韦片剂及其制备方法，组合物包含法匹拉韦或其盐、占组合物重量百分比为2.5％‑15％的崩解剂羧甲基淀粉钠或羧甲基纤维素钙中的一种或两种组合和粘合剂。法匹拉韦组合物药物含量高，可实现法匹拉韦的快速释放，在体外溶出试验中能够在15分钟溶出≥85％。

Drugs covered by this patent

Patent Metadata

Patent number
CN115551484A
Jurisdiction
CN
Classification
—
Expires
2022-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Huahai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.